Maintaining the Highest Ethical Standard in Publishing Stephen P. Spielberg Editorial 30 December 2016 Pages: 396 - 396
TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework Ann Meeker-O’ConnellLeslie M. SamJanis A. Little Sponsored Special Section by TransCelerate BioPharma: Analytical Report Open access 30 December 2016 Pages: 397 - 413
Regulatory System Changes in Russia: A Historical Review and Future Perspectives Raimond Lozda Global Perspectives: Review 30 December 2016 Pages: 414 - 418
Use of Medical Mobile Applications Among Hospital Pharmacists in Malaysia Long Chiau MingMohammed Abdul HameedTahir Mehmood Khan Global Perspectives: Original Research 30 December 2016 Pages: 419 - 426
Consumer Opinions on Existing and Proposed Australian Over-the-Counter Medicine Labeling Strategies in Comparison With the Standardized US Drug Facts Label Vivien TongDavid K. RaynorParisa Aslani Global Perspectives: Original Research 30 December 2016 Pages: 427 - 435
The Impact of Protocol Amendments on Clinical Trial Performance and Cost Kenneth A. GetzStella StergiopoulosDerek Dunn Clinical Trials: Original Research 30 December 2016 Pages: 436 - 441
Mobile Nurse Services in Clinical Trials: Usage and Industry Perceptions Stella StergiopoulosConor EustaceKenneth A. Getz Clinical Trials: Original Research 30 December 2016 Pages: 442 - 449
An Overview of the Regulatory and Developmental Strategies of Chronotherapeutics Mohd. Aamir MirzaFaiyaz ShakeelZeenat Iqbal Clinical Trials: Review 30 December 2016 Pages: 450 - 454
Reporting Adverse Drug Reactions in Product Labels Brenda CroweChristy Chuang-SteinAndreas Brueckner Product Safety: Analytical Report 30 December 2016 Pages: 455 - 463
Best Practices for Improving the Quality of Individual Case Safety Reports in Pharmacovigilance Rishi KumarPranay KumarG. N. Singh Product Safety: Original Research 30 December 2016 Pages: 464 - 471
Applicability of Selective Data Collection to Cancer Clinical Studies for Supplemental Marketing Approvals: Frequency of Adverse Reactions Observed During Supplemental Approval Compared With First Approval Nobuyuki SekineYasuo OhashiAtsushi Aruga Product Safety: Original Research 30 December 2016 Pages: 472 - 479
Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency Jaime ArangoTina ChuckGretchen Wild Regulatory Science: Review Open access 30 December 2016 Pages: 480 - 486
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and Agencies Magdalena BujarNeil McAuslaneStuart Walker Regulatory Science: Original Research 30 December 2016 Pages: 487 - 495
Using Contour Plots to Assess the Sensitivity of Clinical Trial Design Assumptions Richard C. ZinkXiaotong Jiang Statistics: Original Research 30 December 2016 Pages: 496 - 509
Process Innovation Improves Trial Operation Efficiency Yun Jung ChoiKyu-pyo KimTae Won Kim Product Development and Innovation: Original Research 30 December 2016 Pages: 510 - 514
Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs: Time for a Change? Barbara K. RedmanAlison Shea Bateman-House Policy: Commentary 30 December 2016 Pages: 515 - 516
Erratum to: Overcoming organizational challenges of integrating patient-reported outcomes in oncology clinical trials A. GnanasakthyC. DeMuro Erratum 30 December 2016 Pages: 517 - 517
